INTRODUCTION AND OBJECTIVES: Randomized controlled trials (RCTs) are the "gold standard" methodology for determining whether treatment effects are due to chance. The fragility index (FI) is used to determine the number of events that would be required to change significant positive results to non-significant (p>0.05). Herein, we assess the quality of reporting of RCTs in vesicoureteral reflux (VUR) literature using the 2010 CONSORT statement, and for studies with significant positive findings, calculate the FI as a measure of robustness of the results.
INTRODUCTION AND OBJECTIVES: Randomized controlled trials (RCTs) are the "gold standard" methodology for determining whether treatment effects are due to chance. The fragility index (FI) is used to determine the number of events that would be required to change significant positive results to non-significant (p>0.05). Herein, we assess the quality of reporting of RCTs in vesicoureteral reflux (VUR) literature using the 2010 CONSORT statement, and for studies with significant positive findings, calculate the FI as a measure of robustness of the results.
METHODS: A comprehensive search was conducted through MEDLINEâ and Embaseâ to identify RCTs in VUR literature from . Two reviewers independently selected articles, and evaluated them using the 2010 CONSORT checklist. An overall quality of reporting score (OQR) was calculated by dividing the number of checklist items present in each study by the maximum possible score (34) and expressed as a percentage. Studies were classified as low (<40%), moderate (40-70%) and high quality (>70%). A methodological index score (MIS) out of 4 was assigned based on: sample size justification, allocation concealment, randomization method, and blinding of outcome assessors. Of 2052 initial results, 2003 (98%) were excluded because they did not focus on VUR/were not RCTs. After full text screening of 50 articles, we excluded 28 (56%) that did not meet our criteria. For studies reporting significant positive results, we calculated the FI by manually adding events to the group with fewest events until the p value was no longer significant.
RESULTS: Of the 22 included studies, the mean OQR was 45AE16% with 9 (41%) identified as low, 11 (50%) as moderate and 2 (9%) as high quality (Table 1 ). The mean MIS was 1.95AE1. There was no difference in OQR between studies published from 2007-16 (n¼15) versus those before 2007 (n¼7) (41AE15% vs. 44AE20%, p¼0.70) or RCTs with a sample size >100 (n¼15) vs. <100 (n¼7) (40AE15% vs. 46AE17%, p¼0.41). However, we noted a difference when we compared RCTs with biostatistician support (n¼4) vs. those without (n¼18) (62AE9% vs. 40AE14%, p<0.01). 7 studies reported significant positive results making calculation of FI possible. The mean FI was 5.8AE5.1 indicating that most studies were fragile. There was no correlation between the OQS and FI.
CONCLUSIONS: The current OQR in VUR literature is suboptimal. In addition, most FI scores were between 1-5 indicating that only a few events would be required to completely change the results of these studies. Implementation of the CONSORT checklist as a prerequisite for submission of manuscripts may improve the quality of reporting, and calculation of the FI could provide readers with an objective measure of robustness for the reported results.
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MP61-04 THE IPSILATERAL URETERO-URETEROSTOMY: DOES FUNCTION OF THE OBSTRUCTED MOIETY MATTER?
Arun Srinivasan, Trudy Kawal*, Douglas Canning, Thomas Kolon, Stephen Zderic, Aseem Shukla, Philadelphia, PA INTRODUCTION AND OBJECTIVES: Upper pole nephrectomy has been the traditional surgical management of children with poorly functioning upper pole moieties in duplex renal collecting systems having ureteral ectopia or ureterocele. However, ablative surgery confers a risk of functional loss to the remnant moiety due to vasospasm or vascular injury. We hypothesized that Ipsilateral ureteroureterostomy (IUU) is a safe and feasible approach for the management of these patients, and that residual function in the obstructed upper pole does not affect surgical outcomes.
METHODS: All patients who underwent IUU were entered into an IRB approved registry between 2010 to 2016. Only patients with duplex collecting systems were included in the study. Patients were sorted into two groups based on pre-operative imaging: those having < 10% upper pole moiety function (UPMF) and those having !10%. Outcomes assessed were post-operative complications (Clavien-Dindo classification), need for secondary surgery and radiological outcomes.
RESULTS: A total of 62 patients underwent IUU between 2010-2016 (43 robotic, 19 open) . Study cohort comprised 56 children with ectopia or ureterocele affecting the upper pole in a duplex system, 23 with upper pole moiety function (UPMF) <10% (median function 0%, median age 1.49 years) and 33 with UPMF !10% function (median function 15%, median age 0.91 years). Median follow up was 27.4 months and 27.6 months respectively. In both groups, prenatal hydronephrosis was the most common presentation (54.4% and 54.8% respectively) followed by UTI. Mann-Whitney U Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e799 test comparing the two groups revealed no significant differences in any of the outcomes assessed. Overall, no patient required secondary surgery. In the UPMF <10% group, complete resolution of urinary tract dilation was seen in 85.7% of patients while 14.3% of cases had resolution of hydroureter with near complete resolution of hydronephrosis. In the UPMF !10% group these outcomes were 84.6% and 15.4% respectively. Complications occurred in 13.6% of the UPMF<10% group (Clavien grade 2) and 16.1% of the UPMF !10% group (Clavien grades 2 and 3). CONCLUSIONS: IUU is a safe, definitive surgical intervention which preserves the renal architecture in children with duplex collecting systems regardless of upper pole function.
Source of Funding: None
MP61-05 URINARY CARBOHYDRATE ANTIGEN 19-9 LEVEL AS A NOVEL BIOMARKER FOR EARLY DETECTION OF ACUTE PYELONEPHRITIS
Seyedeh Sanam Ladi-Seyedian*, Seyedeh Maryam Kameli, Mastaneh Moghtaderi, Abdol-Mohammad Kajbafzadeh, Tehran, Islamic Republic of Iran INTRODUCTION AND OBJECTIVES: The aim of this study is to evaluate urinary Carbohydrate Antigen 19-9 (CA19-9) levels in early detection of pyelonephritis and its relation with clinical course of the infection and inflammatory changes detected by DMSA.
METHODS: Thirty-five patients with febrile UTI were included in this study as the case group and 30 children who had negative urine culture were nominated as the control group. Urine samples were collected from all participants. Children in case group also underwent complete history and physical examination, kidney and bladder ultrasonography, DMSA, urine analysis and culture. Urine CA19-9 was measured by an electrochemiluminescence enzyme immunometric kit and expressed in U/ml. That level was correlated with clinical factors during statistical analysis.
RESULTS: A total of 65 children were included in this study (mean age: 3 AE 2.8, 12 male and 53 female). CA19-9 levels were significantly greater in the case group than controls (334.30 AE 308 versus 11.68 AE 5.68, P < 0.000). Urine cultures showed that E. coli was the cause of UTI in most cases. CA19-9 levels were significantly higher in the acute phase of febrile UTI and in children with recurrent febrile UTIs and kidney damage. A correlation was found between CA19-9 levels and temperature. No significant association was found regarding age, sex and urinary CA-19-9 levels.
CONCLUSIONS: This study suggests that urine CA19-9 level is markedly increased in pyelonephritis and has potential utility as a predictive biomarker. Also urine CA19-9 levels can be used as an early detection marker for pyelonephritis in children with UTI. The standard treatment for some patients with abnormal bladder function is clean intermittent catheterization (CIC). The goal of this study was to determine the prevalence of urinary tract infections and hospitalizations among children who catheterize the bladder, as compared to children who do not.
Source of
METHODS: The prospective, observational Chronic Kidney Disease in Children (CKiD) study cohort is composed of children, ages 1 to 16, with mild to moderate CKD recruited from 47 North American pediatric nephrology centers. CIC status, hospitalizations and infections were determined using a parent completed questionnaire at study entry or any point along the follow-up for a one-year period. We determined baseline characteristics for this subset and used longitudinal mixed logistic regression models to identify predictors of kidney infections, urinary tract infections and hospitalizations.
RESULTS: A total of 416 CKiD children were included with an underlying urological diagnosis, of whom 105 were on CIC and 311 were not. Median age was 11.9 for CIC and 10.0 for non-CIC patients. Baseline median GFRs were worse in catheter users compared to non-catheter users (53.8 vs 45.6 ml/min/1.73m^2, respectively). Among CIC users, 63% were male, while 71% of noncatheter users were male. Children who catheterized via urethra had on average 3.40-fold odds of hospitalization (95% CI 2.07-5.59, p<0.0001), 4.35-fold odds of bladder infection (95% CI 2.55-7.44, p<0.0001) and 2.56-fold odds of kidney infection (95% CI 1.57-4.17, p¼0.0002) compared to children who did not catheterize. Children who performed catheter use via stoma had 6.48-fold odds of hospitalization (95% CI 3.79-11.11, p<0.0001), 7.69-fold odds of bladder infection (95% CI 4.21-14.05, p<0.0001) and 4.19-fold odds of kidney infection (95% CI 2.55-6.87, p<0.0001) compared to children who did not catheterize. A higher percentage of catheter users were seen by a mental health professional at 33% compared to noncatheter users at 14%. CONCLUSIONS: Children with CKD who perform CIC of the bladder via urethra or stoma comprise a clinically distinct subset with increased risk of negative health outcomes and reported more frequent visits to a mental health provider. Recognizing the needs of this e800 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 
